This Vaccine Maker’s Stock Is Worth Owning
Published
BioNTech, like all Covid-19 vaccine makers, has gotten crunched in 2023. But it has so much cash that it would have appealed to Warren Buffett’s mentor, famed value manager Benjamin Graham.
#warrenbuffetts #benjamingraham